BIO 2026: What to know about the AI Summit
“AI systems will likely have a central role over the next several years in almost every component of the biotech ecosystem,” says Joe Franklin, […]
BIO 2026: What to know about the AI Summit Read More »
BIO Events
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
BIO 2026: Partnering meetings fill up for industry’s biggest gathering
The last time the BIO International Convention was in San Diego, in 2024, Ram May-Ron of the non-dilutive funding specialists FreeMind Group began discussing
BIO 2026: Partnering meetings fill up for industry’s biggest gathering Read More »
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026 Read More »
State of play: BIO Coffee Chat covers how state policies impact access
“We’re finding that the most disruptive pieces of legislation are much more likely to advance in state legislatures first, before eventually gaining traction at
State of play: BIO Coffee Chat covers how state policies impact access Read More »
Experts explain how to drive business development with BIO 2026
The BIO International Convention, the world’s largest annual gathering of biotechnology stakeholders, provides an exceptional opportunity to make the connections that enable development of
Experts explain how to drive business development with BIO 2026 Read More »
BIO on the American Road tours gene therapy hub in Ohio
Ohio’s diverse biotech sector provides the state with employment for 65,000 and provides the world with medical breakthroughs. Of the first eight gene therapies
BIO on the American Road tours gene therapy hub in Ohio Read More »
BIO kicks off ‘Fight of Our Lives,’ highlighting urgency of biotech progress at Axios event
As biotech celebrates its 50th year, we are locked in “the fight of our lives” to ensure patients get more of the medical innovations
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international
BIG Summit themes: Resilient investment, MFN threat, patients in the center Read More »
BIG Summit panel breaks down risks and opportunities coming out of DC
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are
BIG Summit panel breaks down risks and opportunities coming out of DC Read More »
BIG Summit: Experts see signs of M&A momentum in 2026
We could be in for another big year of biotech M&A. A busy 2025, in both licensing and M&A in biopharma, saw over 4,000
BIG Summit: Experts see signs of M&A momentum in 2026 Read More »